• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Sermonix Pharma receives Chinese approval of IND application for lasofoxifene

    PHARMABIZ

    Sermonix Shares Details of Clinical Response in a Metastatic ER+/HER2- Breast Cancer Patient

    GLOBENEWSWIRE

    Sermonix Announces Results of Phase 2 Study of Lasofoxifene vs. Fulvestrant

    GLOBENEWSWIRE

    Sermonix Pharmaceuticals Raises $40M in Series A3 Funding

    FINSMES

    Sermonix Project With Huntsman Cancer Institute Researcher to Investigate

    GLOBENEWSWIRE

    Sermonix to Present Poster on Phase 2 Study of Lasofoxifene in with Eli Lilly

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.